Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
grade C 236.11 2.09% 4.84
BDX closed up 2.09 percent on Thursday, January 17, 2019, on 1.29 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Feb 5

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical BDX trend table...

Date Alert Name Type % Chg
Jan 17 Crossed Above 50 DMA Bullish 0.00%
Jan 17 Above Upper BB Strength 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 17 Upper Bollinger Band Touch Strength 0.00%
Jan 16 NR7 Range Contraction 2.09%
Jan 16 Overbought Stochastic Strength 2.09%
Jan 15 Stochastic Sell Signal Bearish 2.31%
Jan 15 Overbought Stochastic Strength 2.31%
Jan 14 Narrow Range Bar Range Contraction 4.30%

Older signals for BDX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Is BDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 265.87
52 Week Low 208.62
Average Volume 1,278,585
200-Day Moving Average 238.8334
50-Day Moving Average 232.9978
20-Day Moving Average 222.557
10-Day Moving Average 226.864
Average True Range 5.4998
ADX 19.57
+DI 28.2467
-DI 20.772
Chandelier Exit (Long, 3 ATRs ) 220.6106
Chandelier Exit (Short, 3 ATRs ) 225.1194
Upper Bollinger Band 236.1285
Lower Bollinger Band 208.9855
Percent B (%b) 1.0
BandWidth 12.195977
MACD Line -0.0372
MACD Signal Line -2.3698
MACD Histogram 2.3326
Fundamentals Value
Market Cap 53.73 Billion
Num Shares 228 Million
EPS 3.45
Price-to-Earnings (P/E) Ratio 68.44
Price-to-Sales 3.93
Price-to-Book 3.79
PEG Ratio 2.05
Dividend 2.92
Dividend Yield 1.24%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 243.78
Resistance 3 (R3) 243.26 240.18 242.50
Resistance 2 (R2) 240.18 238.23 240.44 242.07
Resistance 1 (R1) 238.15 237.03 239.17 238.67 241.65
Pivot Point 235.07 235.07 235.58 235.33 235.07
Support 1 (S1) 233.04 233.12 234.06 233.56 230.57
Support 2 (S2) 229.96 231.92 230.22 230.15
Support 3 (S3) 227.93 229.96 229.72
Support 4 (S4) 228.45